U.S Government data proves the Covid-19 injections can cause recipients to develop Acquired Immune Deficiency Syndrome and Vaccine Associated Enhanced Disease.
This is why we’re seeing doctors baffled by a sudden surge in Sudden Adult Death Syndrome.
This is why we’re seeing record waiting times in hospitals.
This is why we’re seeing studies published showing vaccinated children suffering sepsis. thrombocytopenia, toxic shock syndrome, autoimmune disease and lymphopenia.
This is why we’re seeing official Government data showing a higher mortality rate among the vaccinated population than the unvaccinated population.
This is why we’re seeing an alleged monkeypox outbreak that is really a cover-up for shingles, herpes, and autoimmune blistering disease.
And this is why we’re seeing more Government data showing the Covid-19 injections have a real-world negative effectiveness of minus-391%.
Acquired Immune Deficiency Syndrome (AIDS) is a condition that can cause a number of potentially life-threatening infections and illnesses to occur when your immune system has been severely damaged. It is a common misconception that it is only caused by the HIV virus.
There are actually several causes of AIDS, and one of the rarer causes is drugs and medications. Data published by the U.S. Government confirms Covid-19 injections should be added to the list of drugs and medications that can lead to recipients developing Acquired Immune Deficiency Syndrome.
The U.S. Centers for Disease Control hosts an online database known as VAERS – the Vaccine Adverse Event Reporting System.
That database reveals that AIDS-related diseases and cancers increased between 1,145% and 33,715% in 2021 against the average number of AIDS-related diseases and cancers reported annually between the years 2000 and 2020.
‘Significant’ Cases of Neurological Disorder Associated With the AstraZeneca Vaccine
A UK study by University College London has confirmed “small but significant” cases of the serious Guillain-Barre syndrome (GBS), a rare neurological disorder associated with the AstraZeneca vaccine for COVID-19.
The researchers speculate that “the majority or all” of the 121 UK cases of GBS (pdf) in March to April 2021 were associated with first doses of the AstraZeneca vaccine administered in January.
“A similar pattern is not seen with the other vaccines or following a second dose of any vaccine,” said lead author Prof. Michael Lunn on May 30.
The team observed that from January to October 2021, 996 GBS cases were recorded in the national database but with an unusual spike from March to April with about 140 cases per month rather than 100.
To identify whether any or all of these cases were linked to vaccination, the team linked dates of GBS onset to vaccination receipt for every individual and found that 198 GBS cases (20 percent of 966) occurred within six weeks of their first dose of COVID-19 vaccination in England; of these, 176 people had an AstraZeneca vaccination, 21 for Pfizer, and 1 for Moderna.
The researchers found no excess GBS cases associated with mRNA vaccines, but observed 5.8 excess cases of GBS per million doses of vaccine for AstraZeneca, equating to a total excess between January to July 2021 of around 98–140 cases, confirming the association between the vaccine and GBS.
GBS is a rare and serious neurological disorder that occurs when the immune system mistakenly attacks its own nerves, typically resulting in numbness, weakness, pain in the limbs, and sometimes even paralysis of breathing.
The disease is commonly associated with Campylobacter infections that prompt the body to attack its own nerves.
However, GBS cases were also observed in the 1976 following administration of the swine flu vaccine as well as modern influenza and yellow fever vaccines, though none of them had rates as high as AstraZeneca.